X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
index medicus (13) 13
aged (10) 10
female (10) 10
male (10) 10
middle aged (8) 8
cardiac & cardiovascular systems (7) 7
stents (6) 6
treatment outcome (6) 6
abridged index medicus (5) 5
angioplasty (5) 5
medicine, general & internal (5) 5
risk (5) 5
atherectomy - methods (4) 4
cardiovascular (4) 4
diabetes (4) 4
double-blind method (4) 4
myocardial infarction (4) 4
outcomes (4) 4
stroke (4) 4
superficial femoral-artery (4) 4
acute coronary syndromes (3) 3
amputation (3) 3
atherectomy (3) 3
balloon angioplasty (3) 3
cardiovascular disease (3) 3
cardiovascular diseases (3) 3
cardiovascular diseases - mortality (3) 3
diabetes mellitus (3) 3
drug dosages (3) 3
heart attacks (3) 3
hypoglycemic agents - adverse effects (3) 3
in-stent restenosis (3) 3
internal medicine (3) 3
lesions (3) 3
mortality (3) 3
patients (3) 3
percutaneous transluminal angioplasty (3) 3
peripheral arterial disease - therapy (3) 3
peripheral artery disease (3) 3
prospective studies (3) 3
risk factors (3) 3
thiazoles - chemistry (3) 3
thiazoles - pharmacology (3) 3
time factors (3) 3
type 2 diabetes (3) 3
acute coronary syndrome (2) 2
aged, 80 and over (2) 2
angina (2) 2
angioplasty, balloon - adverse effects (2) 2
angioplasty, balloon - instrumentation (2) 2
antimalarial activity (2) 2
article (2) 2
association (2) 2
atherectomy - adverse effects (2) 2
atherectomy - instrumentation (2) 2
beta-ketoacyl-acp synthase (2) 2
cardiovascular diseases - epidemiology (2) 2
care and treatment (2) 2
cerebral infarction (2) 2
chemistry, medicinal (2) 2
chocolate candy (2) 2
clinical trials (2) 2
complications (2) 2
computer simulation (2) 2
coronary artery disease (2) 2
coronary heart disease (2) 2
design (2) 2
diabetes mellitus, type 2 - complications (2) 2
diabetes mellitus, type 2 - drug therapy (2) 2
disease (2) 2
dissection (2) 2
distal embolization (2) 2
drug discovery (2) 2
drug therapy (2) 2
excimer laser atherectomy (2) 2
fda approval (2) 2
femoropopliteal artery (2) 2
follow-up studies (2) 2
health risk assessment (2) 2
hemoglobin (2) 2
hospitalization - statistics & numerical data (2) 2
human health and pathology (2) 2
hypoglycemia (2) 2
hypoglycemic agents - therapeutic use (2) 2
incidence (2) 2
inhibitors (2) 2
intervention (2) 2
life sciences (2) 2
mellitus (2) 2
metaanalysis (2) 2
models, molecular (2) 2
mycobacterium tuberculosis (2) 2
patient outcomes (2) 2
percutaneous interventions (2) 2
peripheral arterial disease - surgery (2) 2
pharmacology & pharmacy (2) 2
piperidines - adverse effects (2) 2
plasmodium falciparum (2) 2
plasmodium-falciparum (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2014, Volume 7, Issue 5, pp. 510 - 518
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 18, pp. B314 - B314
  Methods The Chocolate Balloon Angioplasty Registry (Chocolate BAR) is an all-comers registry studying the outcomes of the Chocolate Balloon use, in a... 
Cardiovascular | Internal Medicine | Transluminal angioplasty | Reports | Chocolate candy | Angioplasty | Stents | Dissection | Mortality | Amputation
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 01/2015, Volume 8, Issue 1, pp. 92 - 101
OBJECTIVES: The purpose of this study was to evaluate the safety and efficacy of excimer laser atherectomy (ELA) with adjunctive percutaneous transluminal... 
Peripheral artery disease | In-stent restenosis | Percutaneous transluminal angioplasty | Excimer laser atherectomy | Randomized controlled trial | Femoropopliteal artery | CARDIAC & CARDIOVASCULAR SYSTEMS | excimer laser atherectomy | peripheral artery disease | femoropopliteal artery | in-stent restenosis | LONG-TERM OUTCOMES | LESIONS | randomized controlled trial | PACLITAXEL | percutaneous transluminal angioplasty | IMPLANTATION | SUPERFICIAL FEMORAL-ARTERY | CLINICAL-TRIALS | BALLOON ANGIOPLASTY | DIRECTIONAL ATHERECTOMY | ELUTING BALLOON | NITINOL STENTS | Recurrence | Peripheral Arterial Disease - surgery | Prospective Studies | Constriction, Pathologic | United States | Humans | Middle Aged | Male | Angioplasty, Balloon - adverse effects | Prosthesis Design | Atherectomy - mortality | Lasers, Excimer - therapeutic use | Atherectomy - methods | Time Factors | Popliteal Artery - physiopathology | Amputation | Laser Therapy - adverse effects | Female | Laser Therapy - methods | Popliteal Artery - surgery | Lasers, Excimer - adverse effects | Atherectomy - instrumentation | Stents | Limb Salvage | Femoral Artery - physiopathology | Alloys | Treatment Outcome | Combined Modality Therapy | Angioplasty, Balloon - instrumentation | Laser Therapy - mortality | Peripheral Arterial Disease - mortality | Peripheral Arterial Disease - therapy | Peripheral Arterial Disease - diagnosis | Angioplasty, Balloon - mortality | Aged | Laser Therapy - instrumentation | Chronic Disease | Femoral Artery - surgery | Atherectomy - adverse effects | Vascular Patency
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR SAFETY | MELLITUS | OUTCOMES | MYOCARDIAL-INFARCTION | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9982, pp. 2067 - 2076
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 8, pp. 723 - 732
Journal Article